Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Rangering i aksjer #29898
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Aksjekurs
$1.10
Sist synkronisert: 2023-06-07
Markedsverdi
$19.12M
Endring (1 dag)
-0.90%
Endring (1 år)
0.00%
Land
US
Handel Satsuma Pharmaceuticals, Inc. (STSA)

Kategori

Aksjeprishistorikk for Satsuma Pharmaceuticals, Inc. (STSA)
Høyeste sluttskurs: $1.08 den 2023-06-01

Laveste sluttskurs: $15.51 den 2019-09-01
Aksjeprishistorikk for Satsuma Pharmaceuticals, Inc. fra 2019 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 24.48%
2022 -81.02%
2021 -5.23%
2020 -69.52%
2019 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$737.68 6.34%
CH
$1.07K -5.58%
KR